FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to andrology and endocrinology, and can be used for correction of erectile dysfunction caused by hyperestradiolemia in males. For this purpose, preparation Phosphogliv is administered at 1 capsule 3 times a day (daily dose of 195 mg of phosphatidylcholine/105 mg sodium glycyrrhizinate) for 3 months.
EFFECT: method allows restoring erectile function due to reduced estradiol, prolactin and increase of testosterone-estradiol index.
1 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF HYPERESTRADIOLEMIA AND NORMOGONADOTROPIC HYPOGONADISM IN MALES | 2010 |
|
RU2474424C2 |
| METHOD OF TREATING HYPOGONADOTROPIC HYPOGONADISM, NASAL SPRAY AS METHOD FOR ADMINISTERING GONADORELIN ACETATE IN TREATING HYPOGONADOTROPIC HYPOGONADISM | 2019 |
|
RU2733465C1 |
| METHOD FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES BY PRESCRIBING DIETARY SUPPLEMENTS FOR SEXUAL INTEREST (LIBIDO) RECOVERY IN MALES | 2012 |
|
RU2496491C1 |
| METHOD OF PREDICTION OF CLINICAL EFFECTIVENESS OF TREATMENT WITH CHORIONIC GONADOTROPIN IN MALES WITH HYPOGONADISM | 2015 |
|
RU2604681C1 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF AROMATASE INHIBITORS IN TREATING IDIOPATHIC STERILITY IN MALES SUFFERING OBESITY | 2012 |
|
RU2503008C1 |
| METHOD FOR TREATING PATIENTS AT ERECTILE DYSFUNCTION | 2002 |
|
RU2234330C2 |
| METHOD TO DECREASE DEVELOPMENT OF 5-ALPHA-DIHYDROTESTOSTERONE IN MEN AT AGE ANDROGENIC DEFICIENCY | 1999 |
|
RU2179852C2 |
| DIAGNOSTIC TECHNIQUE FOR HORMONAL DISORDERS IN MEN | 2019 |
|
RU2715565C1 |
| BIOLOGICALLY ACTIVE FOOD ADDITIVE FOR PREVENTION OF MEN'S ERECTILE DYSFUNCTION | 2011 |
|
RU2458537C1 |
| METHOD FOR PREDICTING PARTIAL AGE-CAUSED ANDROGENIC DEFICIENCY (PADAM) | 2002 |
|
RU2231289C2 |
